B. Riley Securities Maintains Buy on Prenetics Global, Lowers Price Target to $31
B. Riley Securities analyst Jeff Van Sinderen maintains Prenetics Global (NASDAQ:PRE) with a Buy and lowers the price target from $37 to $31.
Last updated: 2026-11-22 10:23:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Prenetics Global Limited (PRE) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $8.75, with a market capitalization of $171.73M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.69 to $27.24. This page covers its latest market performance, valuation, price trends and company information.
$171.73M | |
$10.29 | |
$10.45 | |
$8.74 | |
$10.31 | |
578.05K | |
255.28K | |
-- | |
$27.24 | |
$8.69 | |
-- | |
2026-06-30 |
Prenetics Global Limited (PRE) last closed at $8.75 as of 2026-11-21 00:55:00, down 15.28% ($1.58) from the previous close of $10.31.
During the latest regular trading session, PRE traded between $8.75 and $10.45, with a volume of 578.05K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Prenetics Global Limited (PRE) moved from $16.72 to $8.75, representing a decline of 47.67% ($7.97).
The stock traded between $8.69 and $17.83 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 522.54 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.3%
PRE is currently trading at $8.75, placing it 0.3% of the way from its 52-week low of $8.69 to its 52-week high of $27.24. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Prenetics Global Ltd is a consumer health and wellness company offering nutrition and longevity products through its flagship brand, IM8. It offers science-backed daily nutrition and longevity products distributed directly to consumers across multiple countries. The company's products are developed with scientific input and are subject to third-party quality certifications.
| Employees | 98 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Prenetics Global Limited.
Dividend | |
|---|---|
| Ex-Dividend Date | Feb 17, 2016 |
| Payment Date | Mar 1, 2016 |
| Dividend Per Share | $0.7 |
Latest news related to Prenetics Global Limited and PRE stock.
B. Riley Securities analyst Jeff Van Sinderen maintains Prenetics Global (NASDAQ:PRE) with a Buy and lowers the price target from $37 to $31.
Prenetics Global (NASDAQ:PRE) sees Q4 sales of $73.000 million-$83.000 million vs $78.564 million analyst estimate.
U.S. stocks mostly fell, led by a 1.32% Dow drop. Target beat estimates and raised guidance; TJX and Bellring rallied, while oil and metals slid.
Gainers Akanda (NASDAQ:AKAN) shares rose 66.8% to $3.42 during Wednesday's regular session. The market value of their outstanding shares is at $5.4 million. Cue Biopharma (NASDAQ:CUE) shares rose 47.7% to $4.18.
U.S. stocks fell as the Dow slid 300+ points; Nvidia beat Q3 estimates, while energy, commodities and European markets declined.
Eligible investors can buy real shares of Prenetics Global Limited (PRE) through MEXC Stocks. Follow these three steps to open a Stocks account, transfer USDT, and place a Stocks order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to PRE, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between PRE shares and USD.
PRE Shares to USD
1.00 PRE shares = 8.75 USD
Calculations are estimates based on the latest available price and are for reference only.